FDA recall D-0007-2018

Boehringer Ingelheim Pharmaceuticals, Inc. · Class III · drug

Product

Mobic (meloxicam) tablets, 15 mg, package in 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877 USA, Lic. from: BI Int'l GmbH, Made in Italy, NDC 0597-0030-01

Reason for recall

Labeling: Incorrect or missing package insert. One lot of Mobic Tablets is packaged with an incorrect insert.

Distribution

CO, OH

Key facts

Status
Terminated
Initiation date
2017-09-22
Report date
2017-10-18
Termination date
2018-04-18
Voluntary/Mandated
Voluntary: Firm initiated
Location
Danbury, CT, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0007-2018